After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease risk.
Any seasonal impacts of the winter slowdown common with New Zealand slaughtering will be ably covered with Australian production produced and shipped in complete accordance with client requirements, during this period.
Real purpose, real global impact: How Tania Fitzsimons found her greatest opportunity in her own backyard As a flight attendant, Tania Fitzsimons travelled the world: Japan, Germany, Africa, the United States … the impressive list goes on. Yet, south-east Queensland...
From farm life to saving lives: How hard-working mum Nikki Allwell became a leader at our global operation Nikki Allwell is a true blue roll-up-your-sleeves, get-the-job-done kind of person. As a mother raising a young family while working on a farm, she had to be....
Real global impact: How Dylan Pope is shaping his incredible R&D career in the place he least expectedDylan Pope is a driven young chemist who pushes for better every day. Joining Maverick Bio as a Production Technician, he immediately identified the need for a...
An unexpected career: James Gallagher found his great opportunity at #teammaverick - are you ready for yours?Born and bred in Dubbo, James Gallagher had never heard of Maverick Bio. The IT student had relocated to Canberra for his studies, but a reassessment of his...
9th February 2012. Maverick Biomaterials was today awarded ISO 13485:2003 certified by BSI, valid to 8th February 2015.
Subsequent to a recent AQIS Audit Maverick has been granted Intermediate Products listing to the EU. Approval was granted 25th January 2012.